变应原免疫疗法（减敏疗法）的现状：世界卫生组织/国际免疫学会联合会会议纪要
Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.
出版信息
Bull World Health Organ. 1989;67(3):263-72.
Abstract
This Memorandum reviews the present status of allergen immunotherapy, its scientific basis, and the clinical evidence of its efficacy. It also makes recommendations on both indications and contraindications, the most appropriate allergens and treatment regimens, and on prevention and management of adverse reactions. Finally, it indicates future developments in this form of treatment.
摘要
本备忘录回顾了变应原免疫疗法的现状、其科学依据以及疗效的临床证据。它还就适应症和禁忌症、最合适的变应原和治疗方案以及不良反应的预防和管理提出了建议。最后，它指出了这种治疗形式的未来发展方向。
相似文献
1
Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.变应原免疫疗法（减敏疗法）的现状：世界卫生组织/国际免疫学会联合会会议纪要
Bull World Health Organ. 1989;67(3):263-72.
2
Current status of allergen immunotherapy (hyposensitization). Report of a WHO/IUIS working Group.
Allerg Immunol (Leipz). 1989;35(4):235-47.
3
The current status of allergen immunotherapy (hyposensitisation). Report of a WHO/IUIS working group.
Allergy. 1989 Aug;44(6):369-79. doi: 10.1111/j.1398-9995.1989.tb04167.x.
4
[Hyposensitization: indications and expectations].[减敏疗法：适应症与预期]
Padiatr Padol. 1990;25(6):397-404.
5
[Status report on allergen immunotherapy (hyposensitisation). Prepared by the WHO/IUIS Immunotherapy Subcommittee 1988].[变应原免疫疗法（减敏疗法）现状报告。由世界卫生组织/国际免疫学会联盟免疫疗法小组委员会于1988年编写]
Ugeskr Laeger. 1989 Nov 27;151(48):3249-52.
6
[Current aspects of hyposensitization].[减敏治疗的当前进展]
HNO. 1990 Jul;38(7):233-41.
7
Local reactions from subcutaneous allergen immunotherapy.皮下变应原免疫治疗的局部反应。
Immunotherapy. 2013 Dec;5(12):1339-45. doi: 10.2217/imt.13.143.
8
9
Immunological mechanisms of allergen-specific immunotherapy.变应原特异性免疫疗法的免疫机制
Nat Rev Immunol. 2006 Oct;6(10):761-71. doi: 10.1038/nri1934.
10
Allergen-related approaches to immunotherapy.与变应原相关的免疫疗法方法。
Pharmacol Ther. 2009 Mar;121(3):273-84. doi: 10.1016/j.pharmthera.2008.11.007. Epub 2008 Dec 7.
引用本文的文献
1
Isotype-selective abrogation of established IgE responses.已建立的IgE反应的同种型选择性消除。
Clin Exp Immunol. 1990 Dec;82(3):429-34. doi: 10.1111/j.1365-2249.1990.tb05466.x.
本文引用的文献
1
Antibody response following prolonged hyposensitization with Dermatophagoides pteronyssinus extract.用屋尘螨提取物进行长期减敏治疗后的抗体反应。
Int Arch Allergy Appl Immunol. 1980;61(4):431-40. doi: 10.1159/000232471.
2
A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results.
J Allergy Clin Immunol. 1982 Nov;70(5):343-52. doi: 10.1016/0091-6749(82)90023-9.
3
Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E.血清免疫球蛋白E升高的特应性患者中参与体外免疫球蛋白E产生的循环B细胞和调节性T细胞亚群。
J Clin Invest. 1980 Jun;65(6):1457-68. doi: 10.1172/JCI109810.
4
Production and testing of an international reference standard of short ragweed pollen extract.
J Allergy Clin Immunol. 1984 Jun;73(6):790-800. doi: 10.1016/0091-6749(84)90449-4.
5
Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.针对纯化蜂毒蛋白和肽的抗体。II. 对针对单个蜂毒抗原的IgE和IgG抗体变化的详细研究。
J Allergy Clin Immunol. 1983 Oct;72(4):376-85. doi: 10.1016/0091-6749(83)90503-1.
6
Dose response of IgE and IgG antibodies during ragweed immunotherapy.豚草免疫疗法期间IgE和IgG抗体的剂量反应。
J Allergy Clin Immunol. 1984 Jan;73(1 Pt 1):94-104. doi: 10.1016/0091-6749(84)90490-1.
7
A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects.
Clin Allergy. 1984 May;14(3):209-19. doi: 10.1111/j.1365-2222.1984.tb02200.x.
8
IgG4 as a blocking antibody.IgG4作为一种封闭抗体。
Clin Rev Allergy. 1983 Jun;1(2):289-302. doi: 10.1007/BF02991163.
9
Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses.
J Allergy Clin Immunol. 1984 Sep;74(3 Pt 1):230-9. doi: 10.1016/0091-6749(84)90251-3.
10
Prevention of dextran-induced anaphylactic reactions by hapten inhibition. I. A Scandinavian multicenter study on the effects of 10 ml dextran 1, 15% administered before dextran 70 or dextran 40.通过半抗原抑制预防右旋糖酐诱导的过敏反应。I. 一项关于在给予右旋糖酐70或右旋糖酐40之前静脉注射10毫升15%的右旋糖酐1效果的斯堪的纳维亚多中心研究。
Acta Chir Scand. 1983;149(4):341-8.
Zotero 插件